Dual inhibition of AKT ‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer

EMBO Molecular Medicine, EarlyView.
Source: EMBO Molecular Medicine - Category: Molecular Biology Source Type: research